Search results
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 7 days agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 week agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 6 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoImage source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q1 2024 Earnings Call May 06, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and...
What's Going With BioNTech Stock On Monday?
Benzinga· 1 week agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 week agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech (NASDAQ:BNTX) PT Lowered to $122.00 at BMO Capital Markets
ETF DAILY NEWS· 5 days agoBioNTech (NASDAQ:BNTX – Free Report) had its price objective cut by BMO Capital Markets from $123.00 to $122.00 in a report released on Tuesday morning, Benzinga reports.
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 1 week agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 2 weeks agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...